|
|
|
ABBV Dividend History & Description — AbbVie Inc
AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid. When considering the AbbVie Inc stock dividend history, we have taken known splits into account, such that the ABBV dividend history is presented on a split-adjusted ("apples to apples") basis. AbbVie Inc dividend history is presented both in graphical/chart form, and as a ABBV dividend history data table along the right-hand column.
|
ABBV Stock Dividend HistoryThe ABBV dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable ABBV historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the ABBV dividend history record. Also see the ABBV stock dividend history data table along the right-hand column below.
|
|
|
|
Buy (3.17 out of 4)
42nd percentile
|
|
|